Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Texas
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Texas
10 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in Texas.
Cities in Texas
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1622, Houston
- Site Number - 1628, San Antonio
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Austin Neuromuscular Center, Austin
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05327114A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- National Neuromuscular Research Institute, Austin
- NeuroCarePlus, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- NeuroCarePlus, Houston
- National Neuromuscular Research Institute, Irving
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Austin Neuromuscular Center- Site Number : 8400040, Austin
- Gadolin Research - Beaumont- Site Number : 8400047, Beaumont
- Uthealth - The University Of Texas Health Sciences Center At Houston- Site Number : 8400050, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06290141A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Advanced Neurology Epilepsy and Sleep Center/ANESC Research, El Paso
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06752356A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- GC2402 Study Site 106, Sherman
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, Dallas
- Clinical Study Site, Denton
- Cinical Study Site, Houston
- and 3 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT06858579A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Houston Methodist Research Institute, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT06798012A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Neurology Rare Disease Center, Denton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jan 20, 2026 · NCT06747351From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.